vs
欧文斯科宁（OC）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
欧文斯科宁的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs -13.9%，领先41.5%），瑞思迈同比增速更快（11.0% vs -24.6%），欧文斯科宁自由现金流更多（$333.0M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs -3.5%）
欧文斯科宁是美国知名建材及复合材料企业，1935年由康宁玻璃厂与欧文斯-伊利诺伊公司合资组建。主营保温材料、屋面材料、玻璃纤维复合材料及相关产品，是全球最大的玻璃纤维复合材料生产商，全球员工约1.9万人，自1955年《财富》500强榜单创立以来连年上榜。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
OC vs RMD — 直观对比
营收规模更大
OC
是对方的1.5倍
$1.4B
营收增速更快
RMD
高出35.6%
-24.6%
净利率更高
RMD
高出41.5%
-13.9%
自由现金流更多
OC
多$21.8M
$311.2M
两年增速更快
RMD
近两年复合增速
-3.5%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $-298.0M | $392.6M |
| 毛利率 | 23.2% | 61.8% |
| 营业利润率 | -10.5% | 34.6% |
| 净利率 | -13.9% | 27.6% |
| 营收同比 | -24.6% | 11.0% |
| 净利润同比 | -15.5% | 13.9% |
| 每股收益（稀释后） | $-3.47 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OCRMD
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.7B | $1.3B | ||
| Q2 25 | $2.7B | $1.3B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.8B | $1.3B | ||
| Q3 24 | $3.0B | $1.2B | ||
| Q2 24 | $2.8B | $1.2B | ||
| Q1 24 | $2.3B | $1.2B |
净利润OCRMD
| Q4 25 | $-298.0M | $392.6M | ||
| Q3 25 | $-494.0M | $348.5M | ||
| Q2 25 | $363.0M | $379.7M | ||
| Q1 25 | $-93.0M | $365.0M | ||
| Q4 24 | $-258.0M | $344.6M | ||
| Q3 24 | $321.0M | $311.4M | ||
| Q2 24 | $285.0M | $292.2M | ||
| Q1 24 | $299.0M | $300.5M |
毛利率OCRMD
| Q4 25 | 23.2% | 61.8% | ||
| Q3 25 | 28.2% | 61.5% | ||
| Q2 25 | 31.2% | 60.8% | ||
| Q1 25 | 28.7% | 59.3% | ||
| Q4 24 | 28.1% | 58.6% | ||
| Q3 24 | 29.8% | 58.6% | ||
| Q2 24 | 31.1% | 58.5% | ||
| Q1 24 | 29.6% | 57.9% |
营业利润率OCRMD
| Q4 25 | -10.5% | 34.6% | ||
| Q3 25 | -12.2% | 33.4% | ||
| Q2 25 | 18.4% | 33.7% | ||
| Q1 25 | 16.1% | 33.0% | ||
| Q4 24 | -8.5% | 32.5% | ||
| Q3 24 | 16.7% | 31.6% | ||
| Q2 24 | 16.4% | 31.2% | ||
| Q1 24 | 17.5% | 31.3% |
净利率OCRMD
| Q4 25 | -13.9% | 27.6% | ||
| Q3 25 | -18.4% | 26.1% | ||
| Q2 25 | 13.2% | 28.2% | ||
| Q1 25 | -3.7% | 28.3% | ||
| Q4 24 | -9.1% | 26.9% | ||
| Q3 24 | 10.5% | 25.4% | ||
| Q2 24 | 10.2% | 23.9% | ||
| Q1 24 | 13.0% | 25.1% |
每股收益（稀释后）OCRMD
| Q4 25 | $-3.47 | $2.68 | ||
| Q3 25 | $-5.92 | $2.37 | ||
| Q2 25 | $4.25 | $2.58 | ||
| Q1 25 | $-1.08 | $2.48 | ||
| Q4 24 | $-2.92 | $2.34 | ||
| Q3 24 | $3.65 | $2.11 | ||
| Q2 24 | $3.24 | $1.97 | ||
| Q1 24 | $3.40 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $345.0M | $1.4B |
| 总债务越低越好 | $4.7B | $403.9M |
| 股东权益账面价值 | $3.9B | $6.3B |
| 总资产 | $13.0B | $8.5B |
| 负债/权益比越低杠杆越低 | 1.22× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资OCRMD
| Q4 25 | $345.0M | $1.4B | ||
| Q3 25 | $286.0M | $1.4B | ||
| Q2 25 | $230.0M | $1.2B | ||
| Q1 25 | $400.0M | $932.7M | ||
| Q4 24 | $361.0M | $521.9M | ||
| Q3 24 | $499.0M | $426.4M | ||
| Q2 24 | $254.0M | $238.4M | ||
| Q1 24 | $1.3B | $237.9M |
总债务OCRMD
| Q4 25 | $4.7B | $403.9M | ||
| Q3 25 | $4.7B | $408.7M | ||
| Q2 25 | $5.1B | $658.4M | ||
| Q1 25 | $5.0B | $663.1M | ||
| Q4 24 | $5.1B | $662.9M | ||
| Q3 24 | $5.0B | $667.6M | ||
| Q2 24 | $5.0B | $697.3M | ||
| Q1 24 | $2.6B | $997.0M |
股东权益OCRMD
| Q4 25 | $3.9B | $6.3B | ||
| Q3 25 | $4.4B | $6.1B | ||
| Q2 25 | $5.2B | $6.0B | ||
| Q1 25 | $4.9B | $5.5B | ||
| Q4 24 | $5.1B | $5.3B | ||
| Q3 24 | $5.6B | $5.2B | ||
| Q2 24 | $5.5B | $4.9B | ||
| Q1 24 | $5.2B | $4.6B |
总资产OCRMD
| Q4 25 | $13.0B | $8.5B | ||
| Q3 25 | $13.5B | $8.3B | ||
| Q2 25 | $14.5B | $8.2B | ||
| Q1 25 | $14.3B | $7.6B | ||
| Q4 24 | $14.1B | $7.1B | ||
| Q3 24 | $15.1B | $7.2B | ||
| Q2 24 | $15.0B | $6.9B | ||
| Q1 24 | $11.3B | $6.8B |
负债/权益比OCRMD
| Q4 25 | 1.22× | 0.06× | ||
| Q3 25 | 1.06× | 0.07× | ||
| Q2 25 | 0.98× | 0.11× | ||
| Q1 25 | 1.03× | 0.12× | ||
| Q4 24 | 1.01× | 0.13× | ||
| Q3 24 | 0.89× | 0.13× | ||
| Q2 24 | 0.92× | 0.14× | ||
| Q1 24 | 0.51× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $590.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $333.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 15.5% | 21.9% |
| 资本支出强度资本支出/营收 | 12.0% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $962.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流OCRMD
| Q4 25 | $590.0M | $339.7M | ||
| Q3 25 | $918.0M | $457.3M | ||
| Q2 25 | $327.0M | $538.8M | ||
| Q1 25 | $-49.0M | $578.7M | ||
| Q4 24 | $676.0M | $308.6M | ||
| Q3 24 | $699.0M | $325.5M | ||
| Q2 24 | $493.0M | $440.1M | ||
| Q1 24 | $24.0M | $402.0M |
自由现金流OCRMD
| Q4 25 | $333.0M | $311.2M | ||
| Q3 25 | $752.0M | $414.4M | ||
| Q2 25 | $129.0M | $508.2M | ||
| Q1 25 | $-252.0M | $557.9M | ||
| Q4 24 | $479.0M | $288.0M | ||
| Q3 24 | $558.0M | $307.7M | ||
| Q2 24 | $336.0M | $415.2M | ||
| Q1 24 | $-128.0M | $380.8M |
自由现金流率OCRMD
| Q4 25 | 15.5% | 21.9% | ||
| Q3 25 | 28.0% | 31.0% | ||
| Q2 25 | 4.7% | 37.7% | ||
| Q1 25 | -10.0% | 43.2% | ||
| Q4 24 | 16.9% | 22.5% | ||
| Q3 24 | 18.3% | 25.1% | ||
| Q2 24 | 12.0% | 33.9% | ||
| Q1 24 | -5.6% | 31.8% |
资本支出强度OCRMD
| Q4 25 | 12.0% | 2.0% | ||
| Q3 25 | 6.2% | 3.2% | ||
| Q2 25 | 7.2% | 2.3% | ||
| Q1 25 | 8.0% | 1.6% | ||
| Q4 24 | 6.9% | 1.6% | ||
| Q3 24 | 4.6% | 1.5% | ||
| Q2 24 | 5.6% | 2.0% | ||
| Q1 24 | 6.6% | 1.8% |
现金转化率OCRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | 0.90× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 2.18× | 1.05× | ||
| Q2 24 | 1.73× | 1.51× | ||
| Q1 24 | 0.08× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OC
| Insulation | $724.0M | 34% |
| Residential | $625.0M | 29% |
| Doors | $427.0M | 20% |
| Discontinued Operations Disposed Of By Sale | $299.0M | 14% |
| Commercial And Industrial Sector | $101.0M | 5% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
